Form 4: Caris Life Sciences Executive Sells Shares

Luke Thomas Power, Senior Vice President, Chief Financial Officer, and Chief Accounting Officer of Caris Life Sciences, Inc., reported a transaction involving the sale of 9,771 shares of common stock.

Summary

• Luke Thomas Power, an executive at Caris Life Sciences, Inc., reported a transaction on May 15, 2026.
• This transaction involved the disposal of 9,771 shares of common stock.
• The shares were disposed of at a price of $15.25 per share.
• Following this transaction, Mr. Power beneficially owns 153,771 shares of common stock.
• The shares were withheld for the payment of taxes upon the vesting and settlement of Restricted Stock Units (RSUs).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the share disposal is attributed to tax withholding upon RSU vesting, a routine event rather than a discretionary sale.

Negatives

• An executive disposed of a significant number of shares (9,771).

Future Outlook

No specific future outlook or guidance is provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into executive stock dealings. The sale of shares for tax withholding is a common practice upon the vesting of RSUs.

Stakeholder Impact

• Shareholders may note the disposal of shares by an executive, though the reason for tax withholding mitigates immediate concern about a negative outlook.

Key Dates

Keywords

Form 4, Insider Transaction, Caris Life Sciences, Common Stock, Share Sale, Executive Compensation, Tax Withholding